William L. Bayer

978 total citations
40 papers, 740 citations indexed

About

William L. Bayer is a scholar working on Hematology, Epidemiology and Physiology. According to data from OpenAlex, William L. Bayer has authored 40 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 9 papers in Epidemiology and 9 papers in Physiology. Recurrent topics in William L. Bayer's work include Blood groups and transfusion (8 papers), Erythrocyte Function and Pathophysiology (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). William L. Bayer is often cited by papers focused on Blood groups and transfusion (8 papers), Erythrocyte Function and Pathophysiology (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). William L. Bayer collaborates with scholars based in United States, China and France. William L. Bayer's co-authors include Gary E. Tegtmeier, Jessica H. Lewis, Malcolm L. Beck, M. L. Beck, Frank E. Sherman, Richard H. Michaels, Jane M. Rachel, Robert L. Hardesty, Fred V. Plapp and Henry T. Bahnson and has published in prestigious journals such as New England Journal of Medicine, Blood and PEDIATRICS.

In The Last Decade

William L. Bayer

38 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William L. Bayer United States 15 312 249 149 118 105 40 740
Patricia Pisciotto United States 14 368 1.2× 167 0.7× 66 0.4× 117 1.0× 294 2.8× 29 808
S. Gerald Sandler United States 16 389 1.2× 122 0.5× 175 1.2× 62 0.5× 165 1.6× 49 756
Hans‐Gert Heuft Germany 18 255 0.8× 204 0.8× 52 0.3× 119 1.0× 91 0.9× 52 745
Vincent J. Freda United States 17 503 1.6× 71 0.3× 181 1.2× 90 0.8× 40 0.4× 43 892
Allyn B. Ley United States 12 255 0.8× 105 0.4× 98 0.7× 30 0.3× 21 0.2× 22 675
Kenneth A. Starling United States 19 212 0.7× 73 0.3× 300 2.0× 163 1.4× 21 0.2× 57 1.2k
Byron A. Myhre United States 15 219 0.7× 36 0.1× 183 1.2× 26 0.2× 249 2.4× 59 718
A. R. Bird South Africa 14 152 0.5× 261 1.0× 54 0.4× 46 0.4× 33 0.3× 41 588
Dolly Daniel India 15 175 0.6× 273 1.1× 72 0.5× 69 0.6× 16 0.2× 53 673
F. Ala Iran 13 237 0.8× 129 0.5× 28 0.2× 30 0.3× 72 0.7× 38 532

Countries citing papers authored by William L. Bayer

Since Specialization
Citations

This map shows the geographic impact of William L. Bayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William L. Bayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William L. Bayer more than expected).

Fields of papers citing papers by William L. Bayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William L. Bayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William L. Bayer. The network helps show where William L. Bayer may publish in the future.

Co-authorship network of co-authors of William L. Bayer

This figure shows the co-authorship network connecting the top 25 collaborators of William L. Bayer. A scholar is included among the top collaborators of William L. Bayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William L. Bayer. William L. Bayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dowell, Scott F., Thomas J. Török, James A. Thorp, et al.. (1995). Parvovirus B19 Infection in Hospital Workers: Community or Hospital Acquisition?. The Journal of Infectious Diseases. 172(4). 1076–1079. 25 indexed citations
2.
Bayer, William L., et al.. (1995). A Technique for von Willebrand Multimer Analysis Applicable to the Clinical Laboratory. Clinical and Applied Thrombosis/Hemostasis. 1(1). 31–33. 1 indexed citations
3.
Bayer, William L., David Bodensteiner, Lowell Tilzer, & Mary G. Adams. (1992). Use of Platelets and Other Transfusion Products in Patients with Malignancy. Seminars in Thrombosis and Hemostasis. 18(4). 380–391. 16 indexed citations
4.
Bodensteiner, David, et al.. (1992). Use of Blood Components in Cancer Patients With Bleeding. Hematology/Oncology Clinics of North America. 6(6). 1375–1392. 3 indexed citations
5.
Hoff, Gerald L., et al.. (1991). Voluntary Human Immunodeficiency Virus Testing I Acceptance Levels and Identification of Seropositive Individuals. Southern Medical Journal. 84(2). 198–199. 1 indexed citations
6.
Lee, James H., et al.. (1990). Voluntary Human Immunodeficiency Virus Testing, Recidivism, Partner Notification, and Sero-Prevalence in a Sexually Transmitted Disease Clinic. Sexually Transmitted Diseases. 17(4). 169–174. 14 indexed citations
7.
Rachel, Jane M., et al.. (1985). A solid-phase red cell adherence test for platelet cross-matching.. PubMed. 42(2). 194–5. 37 indexed citations
8.
Tegtmeier, Gary E., et al.. (1985). Early and late antigens of human cytomegalovirus:Electroimmunodiffusion assay of numbers, relationships, and reactivities with donor sera. Journal of Medical Virology. 15(2). 137–148. 3 indexed citations
9.
Beneke, J, et al.. (1984). Relation of Titers of Antibodies to CMV in Blood Donors to the Transmission of Cytomegalovirus Infection. The Journal of Infectious Diseases. 150(6). 883–888. 51 indexed citations
11.
Tegtmeier, Gary E., et al.. (1979). Antigens of Human Cytomegalovirus: Electroimmunodiffusion Assay and Comparison Among Strains. Journal of General Virology. 43(3). 707–712. 5 indexed citations
12.
Belcher, C., et al.. (1977). Effect of Hydroxyethyl Starch on Platelet Function Following Granulocyte Collection Using the Continuous Flow Cell Separator. Transfusion. 17(6). 635–637. 10 indexed citations
13.
Bayer, William L. & Gary E. Tegtmeier. (1976). The blood donor: detection and magnitude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibody.. PubMed. 49(1). 5–12. 38 indexed citations
14.
Beck, M. L., et al.. (1976). Serologic Activity of Fatty Acid Dependent Antibodies in Albumin‐Free Systems. Transfusion. 16(5). 434–436. 4 indexed citations
15.
Noble, Gary R., et al.. (1975). Cytomegalovirus infection in a volunteer blood donor population. Infection and Immunity. 11(4). 719–723. 66 indexed citations
16.
Lewis, Jessica H., et al.. (1972). Leukofibrinolysis. Blood. 40(6). 844–855. 9 indexed citations
17.
Hardesty, Robert L., William L. Bayer, & Henry T. Bahnson. (1968). A technique for the use of autologous fresh blood during open-heart surgery. Journal of Thoracic and Cardiovascular Surgery. 56(5). 683–688. 31 indexed citations
18.
Bayer, William L., et al.. (1965). Allergic Tracheobronchitis Due to Nitrofurantoin Sensitivity. Diseases of the Chest. 48(4). 429–430. 13 indexed citations
19.
Bayer, William L.. (1960). Klinische Erfahrungen mit Kanamycin*. DMW - Deutsche Medizinische Wochenschrift. 85(4). 155–158. 1 indexed citations
20.
Bayer, William L.. (1955). [Nutrition of the expectant mother; prophylaxis of the infant].. PubMed. 8. 273–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026